Skip to main content
. Author manuscript; available in PMC: 2020 Dec 1.
Published in final edited form as: Surgery. 2019 Sep 13;166(6):1122–1127. doi: 10.1016/j.surg.2019.07.014

Table 2. Trauma patient population demographics, hematology and clinical outcomes.

Numbers presented as median with 25 and 75 interquartile range or raw number with percent total as appropriate.

Demographics
Age (y) 33.5 (25.5-46.6)
% male 44 (76%)
Injury Characteristics
% blunt mechanism 32 (55%)
Time from injury to arrival (min) 27 (21-34)
NISS 17 (9-34)
% TBI 18 (31%)
Laboratory Values
SBP (mm Hg) 119 (92-136)
Lactate (mmol/L) 3.5 (2.2-6.6)
Base deficit (meq/L) 5.8 (3.4-10.6)
PT/INR 1.1 (1.0-1.2)
PTT (s) 25.8 (23.3-27.9)
Thrombelastography
ACT (seconds) 105 (97-121)
Angle (degrees) 74.4 (67.6-77.8)
MA (mm) 62.0 (57.5-65.0)
LY30 (%) 1.6 (0.5-3.0)
Whole Blood Thrombin Generation
Lag time (min) 3.8 (2.8-4.9)
Peak thrombin (nM) 86.4-146.7)
Time to peak thrombin (min) 6.7 (4.9-9.1)
Maximum rate (nM/min) 42.6 (22.9-61.6)
ETP (nM.min) 823 (711-966)
Clinical Outcomes
RBCs/1st 6 h (units) 0 (0-2)
% massive transfusion (>10 units RBCs/1st 6 ) 3 (5%)
ICU LOS (days) 3 (0-5)
Ventilator days 1 (0-3)
Hospital duration of stay (days) 4 (3-13)
% mortality 10 (17%)

NISS=new injury severity score, TBI=traumatic brain injury (defined as head and neck abbreviated injury score ≥ 3), SBP=systolic blood pressure, PT/INR=prothrombin time/international normalized ratio, PTT=activated partial prothrombin time, ACT=activating clotting time, MA=maximum amplitude, LY30=fibrinolysis 30 minutes after MA, ETP=endogenous thrombin potential, RBC=red blood cells, ICU=intensive care unit,